Innoviva

INVANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.520 B

$21.04 -0.47%

Close of 21 Sept 2026

Revenue

$411.3M

#2007 by revenue

Earnings

—

Not reported

Shares outstanding

72,245,485

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#127Kailera TherapeuticsKLRA$1.55B
#128KardiganKARD$1.52B
#129InnovivaINVA$1.52B
#130Ascentage Pharma Group InternationalAAPG$1.48B
#131ArriVent BioPharmaAVBP$1.47B

What if Innoviva were worth as much as…

Open the what-if tool →

Gold $30.3T

$419,044.24

Per share 19,917× higher

Bitcoin $1.72T

$23,805.00

Per share 1,131× higher

Nvidia $5.48T

$75,850.53

Per share 3,605× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Innoviva are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.